Back to search results

AI-Assisted Imaging Report Summaries for Oncology Patients

This study is looking at how well AI-assisted, patient-friendly imaging report summaries help people with cancer understand their scan results. It's an observational study, meaning researchers will watch what happens without giving new treatments. You could join if you are 18 or older, have a current or past cancer diagnosis, use the UW Health MyChart patient portal, and receive care at UW Health in specific oncology departments. The study aims to see if these summaries make your results easier to understand and reduce anxiety. Success will be measured by how many patients find the information "Somewhat easy to understand" or "Very easy to understand," and how providers feel about patient questions after the summaries are introduced. The current status of the study is unclear.

Study design
This is an observational study planning to include 2000 participants. It uses surveys to gather feedback from patients and providers before and after the AI tool is implemented.
What's involved
You would provide feedback through surveys at the beginning of the study and after the AI summaries are in use. A small number of participants will also be interviewed.
Compensation
Not stated in the trial record.
Follow-up
Patient understanding is measured up to 15 minutes after reviewing results. Provider workload is measured at baseline and 3 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07532083

Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery

Recruiting
Not specifiedAges 18+Observational
University of Wisconsin, Madison
~2,000 participants
Updated 2026-08-05 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Proportion of Patient Participants who report the information presented in their results is "Somewhat easy to understand" or "Very easy to understand" when reviewed by themselves
Measured over up to 15 minutes
+1 more outcome measured

Conditions

Oncology

Explore related trials

Malignant Neoplasm

Where it's being run

1 sites across 1 states
Wisconsin1

Study leadership

  • Toby Campbell, MD · PRINCIPAL_INVESTIGATOR · UW School of Medicine and Public Health

Who to contact

Supportive Oncology
[email protected]
608-263-6002
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 years or older
Having a current or prior cancer diagnosis (any cancer type)
Has active access to the UW Health MyChart patient portal.
Receiving care at UW Health within the Division of Hematology, Medical Oncology and Palliative Care or Department of Gynecologic Oncology.
Undergoing imaging studies (such as CT, MRI, or PET scans) as part of routine cancer care.
Willing and able to complete electronic REDCap surveys.
For interview participation: willing to participate in a 30-45-minute phone or video interview.
Faculty physician (MD or DO) practicing in the Division of Hematology, Medical Oncology and Palliative Care or Department of Gynecologic Oncology at UW Health.
Involved in reviewing, discussing, or sharing imaging results with patients.
Planned to gain access to the AI-assisted, patient-friendly imaging summary tool as part of clinical implementation.
Willing and able to complete electronic surveys or participate in a brief interview (\~30 minutes).

Exclusion

Are unable to provide informed consent due to cognitive impairment or other limitations, as determined by the clinical or study team.
Enrolled in an active interventional clinical trial. Patients on biospecimen, registry, or non-interventional studies are eligible.
For the Patient Interview group only: Patients with radiographic disease progression will be excluded.

What this trial measures

  • Proportion of Patient Participants who report the information presented in their results is "Somewhat easy to understand" or "Very easy to understand" when reviewed by themselvesup to 15 minutes

    Baseline data collected in a 10-15 minute survey from patient participants pre-implementation and in a 10-15 minute survey from patient participants post-implementation.

  • Perceived impact of scan-result-related patient queries on Provider Participant workloadbaseline, 3 months

    Scored from 1 (no impact) to 5 (very frequently), higher scores indicate higher impact on workload. Data collected at baseline (pre-implementation) and 3 months (post-implementation).